Close
ACHEMA MIDDLE EAST 2026

FDA lifts partial clinical hold on OncoMed’s vantictumab cancer drug trials

The US Food and Drug Administration (FDA) has lifted a partial hold on patient enrolments for three Phase Ib clinical trials evaluating OncoMed Pharmaceuticals'...

InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN®

InnoPharma, Inc. today announced the approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for decitabine for...

Novo Nordisk introduces Ryzodeg in Mexico for type 2 diabetes

Denmark-based Novo Nordisk has introduced Ryzodeg (insulin degludec/insulin aspart) in Mexico, which will be used to treat adult patients suffering from type 2 diabetes....

Senesco completes patient enrolment in Phase Ib/IIa SNS01-T trial

US-based biotech firm Senesco Technologies has completed patient enrolment in its ongoing Phase Ib/IIa clinical trial of SNS01-T to treat patients with relapsed or...

Asterias to begin AST-OPC1 Phase I/IIa trial to treat spinal cord injury

The US Food and Drug Administration (FDA) has granted clearance to Asterias Biotherapeutics for the initiation of a Phase I/IIa clinical trial of its...

BIOGEN IDEC names adriana karaboutis evp, technology and business solutions

Biogen Idec (NASDAQ: BIIB) today announced the appointment of Adriana (Andi) Karaboutis as executive vice president, Technology and Business Solutions, effective September 24, 2014....

FDA plans to take steps to enhance the collection and availability of clinical trial data on demographic subgroups.

  By: Margaret A. Hamburg, M.D.Margaret A. Hamburg, M.D., is Commissioner of the U.S. Food and Drug Administration   August 20, 2014, Today...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...